Fingolimod for Irradiation-Induced Neurodegeneration
BackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00699/full |
id |
doaj-1ff3b6d43f3e49c5b4b89b722eaaa9a6 |
---|---|
record_format |
Article |
spelling |
doaj-1ff3b6d43f3e49c5b4b89b722eaaa9a62020-11-25T01:54:36ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-07-011310.3389/fnins.2019.00699451355Fingolimod for Irradiation-Induced NeurodegenerationJudith Metzdorf0Zaynab Hobloss1Sibylle Schlevogt2Ilya Ayzenberg3Ilya Ayzenberg4Sarah Stahlke5Xiomara Pedreiturria6Steffen Haupeltshofer7Ralf Gold8Lars Tönges9Ingo Kleiter10Ingo Kleiter11Department of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, I.M. Sechenov First Moscow State Medical University, Moscow, RussiaDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyMarianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, GermanyBackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would be beneficial. Fingolimod (FTY720), a sphingosine-1-phosphate receptor modulator approved for multiple sclerosis, is an immunosuppressant and known to enhance proliferation and differentiation of neuronal precursor cells (NPCs).ObjectivesTo investigate whether pre-treatment with FTY720 protects NPCs in vitro and in vivo from irradiation-induced damage.MethodsNeuronal precursor cells were isolated from E13 C57BL/6 wildtype mice, treated at day 0 of differentiation with FTY720 and irradiated on day 6 with 1 Gy. NPCs were analyzed for markers of cell death (PI, caspase-3), proliferation (Ki67), and differentiation (DCX, βIII-tubulin). Adult C57BL/6 wildtype mice were treated with FTY720 (1 mg/kg) and received a single dose of 6 Gy cranial irradiation at day 7. Using immunohistochemistry, we analyzed DCX and BrdU as markers of neurogenesis and Iba1, GFAP, and CD3 to visualize inflammation in the dentate gyrus (DG) and the subventricular zone (SVZ). B6(Cg)-Tyrc-2J/J DCX-luc reporter mice were used for bioluminescence imaging to evaluate the effect of FTY720 on neurogenesis in the DG and the spinal cord of naïve mice.ResultsFTY720 protected NPCs against irradiation induced cell death in vitro. Treatment with FTY720 dose-dependently reduced the number of PI+ cells 24 and 96 h after irradiation without effecting proliferation or neuronal differentiation. In vivo treatment resulted in a significant survival of DCX+ neurons in the DG and the SVZ 4 weeks after irradiation as well as a slight increase of proliferating cells. FTY720 inhibited microglia activation 24 h after X-ray exposure in the DG, while astrocyte activation was unaffected and no lymphocyte infiltrations were found. In naïve mice, FTY720 treatment for 4 weeks had no effect on neurogenesis.ConclusionFTY720 treatment of NPCs prior to X-ray exposure and of mice prior to cranial irradiation is neuroprotective. No effects on neurogenesis were found.https://www.frontiersin.org/article/10.3389/fnins.2019.00699/fullfingolimodneuroprotectionX-rayradiationneurogenesisneuronal precursor cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Judith Metzdorf Zaynab Hobloss Sibylle Schlevogt Ilya Ayzenberg Ilya Ayzenberg Sarah Stahlke Xiomara Pedreiturria Steffen Haupeltshofer Ralf Gold Lars Tönges Ingo Kleiter Ingo Kleiter |
spellingShingle |
Judith Metzdorf Zaynab Hobloss Sibylle Schlevogt Ilya Ayzenberg Ilya Ayzenberg Sarah Stahlke Xiomara Pedreiturria Steffen Haupeltshofer Ralf Gold Lars Tönges Ingo Kleiter Ingo Kleiter Fingolimod for Irradiation-Induced Neurodegeneration Frontiers in Neuroscience fingolimod neuroprotection X-ray radiation neurogenesis neuronal precursor cells |
author_facet |
Judith Metzdorf Zaynab Hobloss Sibylle Schlevogt Ilya Ayzenberg Ilya Ayzenberg Sarah Stahlke Xiomara Pedreiturria Steffen Haupeltshofer Ralf Gold Lars Tönges Ingo Kleiter Ingo Kleiter |
author_sort |
Judith Metzdorf |
title |
Fingolimod for Irradiation-Induced Neurodegeneration |
title_short |
Fingolimod for Irradiation-Induced Neurodegeneration |
title_full |
Fingolimod for Irradiation-Induced Neurodegeneration |
title_fullStr |
Fingolimod for Irradiation-Induced Neurodegeneration |
title_full_unstemmed |
Fingolimod for Irradiation-Induced Neurodegeneration |
title_sort |
fingolimod for irradiation-induced neurodegeneration |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroscience |
issn |
1662-453X |
publishDate |
2019-07-01 |
description |
BackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would be beneficial. Fingolimod (FTY720), a sphingosine-1-phosphate receptor modulator approved for multiple sclerosis, is an immunosuppressant and known to enhance proliferation and differentiation of neuronal precursor cells (NPCs).ObjectivesTo investigate whether pre-treatment with FTY720 protects NPCs in vitro and in vivo from irradiation-induced damage.MethodsNeuronal precursor cells were isolated from E13 C57BL/6 wildtype mice, treated at day 0 of differentiation with FTY720 and irradiated on day 6 with 1 Gy. NPCs were analyzed for markers of cell death (PI, caspase-3), proliferation (Ki67), and differentiation (DCX, βIII-tubulin). Adult C57BL/6 wildtype mice were treated with FTY720 (1 mg/kg) and received a single dose of 6 Gy cranial irradiation at day 7. Using immunohistochemistry, we analyzed DCX and BrdU as markers of neurogenesis and Iba1, GFAP, and CD3 to visualize inflammation in the dentate gyrus (DG) and the subventricular zone (SVZ). B6(Cg)-Tyrc-2J/J DCX-luc reporter mice were used for bioluminescence imaging to evaluate the effect of FTY720 on neurogenesis in the DG and the spinal cord of naïve mice.ResultsFTY720 protected NPCs against irradiation induced cell death in vitro. Treatment with FTY720 dose-dependently reduced the number of PI+ cells 24 and 96 h after irradiation without effecting proliferation or neuronal differentiation. In vivo treatment resulted in a significant survival of DCX+ neurons in the DG and the SVZ 4 weeks after irradiation as well as a slight increase of proliferating cells. FTY720 inhibited microglia activation 24 h after X-ray exposure in the DG, while astrocyte activation was unaffected and no lymphocyte infiltrations were found. In naïve mice, FTY720 treatment for 4 weeks had no effect on neurogenesis.ConclusionFTY720 treatment of NPCs prior to X-ray exposure and of mice prior to cranial irradiation is neuroprotective. No effects on neurogenesis were found. |
topic |
fingolimod neuroprotection X-ray radiation neurogenesis neuronal precursor cells |
url |
https://www.frontiersin.org/article/10.3389/fnins.2019.00699/full |
work_keys_str_mv |
AT judithmetzdorf fingolimodforirradiationinducedneurodegeneration AT zaynabhobloss fingolimodforirradiationinducedneurodegeneration AT sibylleschlevogt fingolimodforirradiationinducedneurodegeneration AT ilyaayzenberg fingolimodforirradiationinducedneurodegeneration AT ilyaayzenberg fingolimodforirradiationinducedneurodegeneration AT sarahstahlke fingolimodforirradiationinducedneurodegeneration AT xiomarapedreiturria fingolimodforirradiationinducedneurodegeneration AT steffenhaupeltshofer fingolimodforirradiationinducedneurodegeneration AT ralfgold fingolimodforirradiationinducedneurodegeneration AT larstonges fingolimodforirradiationinducedneurodegeneration AT ingokleiter fingolimodforirradiationinducedneurodegeneration AT ingokleiter fingolimodforirradiationinducedneurodegeneration |
_version_ |
1724986333223452672 |